Senior insider sale
RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$467.5K
130K shares
What this filing means
BORGESON BLAKE plans to sell 130K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $467.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/7/2026ACC: 0001959173-26-005138
Director
Since Apr 2021
130K
Shares to sell
$467.5K
Approx. market value
40K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Founder's Shares
Compensation
9/19/2017
40KTotal acquired40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/19/2017 | Founder's Shares Compensation | 40K | — |
| Total | 40K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
30K
Market value
$110.4K
6/2/2026
—Completed
Units to sell
30K
Market value
$105.6K
5/5/2026
—Completed
Units to sell
30K
Market value
$93.0K
4/7/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
40K
Market value
$158.5K
7/7/2026
Total
Units
130K
Value
$467.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/2/2026 | 30K | $110.4K | — | Completed |
5/5/2026 | 30K | $105.6K | — | Completed |
4/7/2026 | 30K | $93.0K | — | Completed |
| Planned — Approximate Date | ||||
7/7/2026 | 40K | $158.5K | NASDAQ | Planned |
| Total | 130K | $467.5K | ||